When was Stable Pharma founded?

Stable Pharma was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Where is Stable Pharma located?

Stable Pharma is headquartered in Bath, United Kingdom.

Which legal entities is Stable Pharma associated with?

Stable Pharma is associated with Stablepharma Limited.

How many employees does Stable Pharma have?

As of Jul 31, 2026, the latest employee count at Stable Pharma is 27.

Is Stable Pharma a funded company?

Stable Pharma is a funded company, having raised a total of $5M across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 01, 2015.

When was the latest funding round of Stable Pharma?

Stable Pharma's latest funding was a $***** Series B round on May 2026, with participation from 1 investor.

Where does Stable Pharma rank among its competitors?

Stable Pharma ranks 66th amongst 2038 active competitors, of which 472 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Stable Pharma, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Stable Pharma?

Stable Pharma's top competitors include Synthego, Antheia and Transcenta. Among them, Stable Pharma secured the most recent funding round in May, 2026.

Stable Pharma - 2026 Company Profile, Funding, Competitors & Financials

Stable Pharma is a series B company based in Bath (United Kingdom), founded in 2011. It operates as a Developer of technology to store and deliver stable drugs and vaccines. Stable Pharma has raised $5M in funding from Ascension. The company has 2038 active competitors, including 472 funded and 341 that have exited. Its top competitors include companies like Synthego, Antheia and Transcenta.

Company Details

Developer of technology to store and deliver stable drugs and vaccines. The company process allows the precise dosage to be pre-loaded into the syringe at the point of manufacture thus eliminating wastage, reducing costs, and ensuring a correct dose is delivered to every patient. As the vaccine is stored in a stable state it is not temperature sensitive so this removes the necessity for refrigeration.

Key Metrics

Founded Year

2011

Location

Bath, United Kingdom

Stage

Series B

Total Funding

$5M in 5 rounds

Latest Funding Round

Series B, May 2026, $*****

Investors

Ascension & 79 more

Ranked

66^th among 2038 active competitors

Employee Count

27 as on Jul 31, 2026

Similar Companies

Synthego & 2723 more

View Stable Pharma's full profile

Stable Pharma is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Stablepharma Limited CIN: 7925414 , Germany, Active	Jan 25, 2012	-	1 (As on Jan 31, 2020)

Stable Pharma has raised a total funding of $5M over 5 rounds. Its first funding round was on Sep 01, 2015. Its latest funding round was a Series B round on May 2026 for $*****. 1 investor participated in its latest round. Stable Pharma has 11 institutional investors and 69 angel investors.

Here is the list of recent funding rounds of Stable Pharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 2026	2631997	Series B	3295738	8076544	9180493	9813221
Sep 17, 2021	8429703	Series A	2358238	4083046	9920373	2252913
Jun 30, 2019	7327457	Seed	9073831	9699379	3513380	7324231

Access funding benchmarks and valuations. Sign up today!

View details of Stable Pharma's funding rounds and investors

Stable Pharma's employee count trend

Stable Pharma has 27 employees as of Jul 26. Here is Stable Pharma's employee count trend over the years:

Uncover Stable Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Stable Pharma include Synthego, Antheia and Transcenta. Here is the list of Top 10 competitors of Stable Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, Perceptive Advisors & 30 others	71/100
2nd	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
3rd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
4th	Judges Scientific 2002, London (United Kingdom), Public	Acquisition and development of scientific instrument businesses	-	Origin Capital, Lloyds Banking Group	65/100
5th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Orbimed, Sino Biopharmaceutical & 18 others	65/100
6th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Fidelity Investments ... & 14 others	64/100
7th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Bpifrance & 14 others	63/100
8th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	UBS, Brown Brothers Harriman & 1 others	63/100
9th	Dewpoint Therapeutics 2018, Boston (United States), Series D	Developer of small molecule based therapeutics	$346M	Maverick Ventures, Polaris Partners & 16 others	62/100
10th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 6 others	62/100
66th	Stable Pharma 2011, Bath (United Kingdom), Series B	Developer of technology to store and deliver stable drugs and vaccines	$5M	Ascension, EIC Fund & 78 others	54/100